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Abstract
Introduction: Hysterectomy has been one of the most common surgical procedures in 
women in Finland. We studied the population- based trends of hysterectomy and its 
indications from 1986 to 2017.
Material and methods: A retrospective population- based cohort was created from the 
Care Register for Health Care by identifying women who had a hysterectomy from 
1986 to 2017 and calculating the number of women from the Digital and Population 
Data Services Agency. We estimated the number and incidence of hysterectomy by 
period and age as well as by indication. We considered the primary diagnosis at the 
time of surgery as the indication of hysterectomy.
Results: The number of hysterectomies increased from 7492 procedures in 1986 to 
12 404 procedures in 1998, and reduced substantially after that to 5971 procedures 
in 2017, the turning point being in 1999. The incidence rate of hysterectomy has de-
creased on average by 2.5% annually from 432.6 per 100 000 women in 1998– 2001 
to 224.5 per 100 000 women in 2014– 2017. The median age at the time of hyster-
ectomy has increased from 51 years in 1998– 2001 to 55 years in 2014– 2017. The 
cumulative burden of hysterectomy by age of 60 years has nearly halved from the 
first 4- year period (23%) to the last (12%). After 2010, the most common indication 
has been genital prolapse and incontinence, whereas earlier it was uterine fibroids.
Conclusions: The number and incidence of hysterectomies have fluctuated during the 
observation period 1986– 2017 and decreased considerably during the past 17 years 
in Finland. This is probably a result of the availability of hormonal and other conserva-
tive treatment options for bleeding disorders and uterine fibroids. As hysterectomy 
practically removes the risk for endometrial cancer, the change in hysterectomy in-
cidence over time emphasizes the importance of correcting endometrial cancer inci-
dence according to hysterectomy incidence.
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1  |  INTRODUC TION
Hysterectomy, i.e. surgical removal of the uterus, has been 
one of the most commonly performed surgical procedures in 
women.1 The majority of hysterectomies are performed for be-
nign indications. The typical benign indications for hysterec-
tomy include uterine fibroids, menorrhagia, uterine prolapse and 
endometriosis.2– 4 Malignant indications include endometrial, ovar-
ian and cervical cancers.3,4 In Finland, hysterectomy rates have 
been historically high, as approximately one- fifth of women aged 
45– 64 years were reported to have undergone the procedure by 
1989.5 Hysterectomy incidence was still increasing in Finland in 
the 1990s.6 During the last two decades, since 2000, new treat-
ment options especially for benign conditions such as bleeding 
disorders and uterine fibroids have emerged.7 These alternative 
treatment methods include hormonal treatments such as the 
levonorgestrel- releasing intrauterine system (LNG- IUS), endome-
trial ablation, uterine artery embolization, operative hysteroscopy 
and pharmaceutical treatment.7,8 The current Finnish treatment 
guidelines recommend alternative options to hysterectomy as the 
primary treatment in benign diseases and more invasive surgical 
interventions such as hysterectomy can be used if conservative 
treatment has failed.8– 11 The incidence of hysterectomy has lately 
markedly decreased in Finland.6,12 The reason for this may be de-
velopment of these alternative options to hysterectomy in the 
treatment of gynecological conditions.
Hysterectomy, either total or supracervical, practically re-
moves the risk of future endometrial cancer and total hysterec-
tomy removes the risk of future cervical cancer also. Therefore, 
the number of hysterectomies performed in the population af-
fects the incidence and absolute number of these cancers in 
the population. This is particularly significant in the case of en-
dometrial cancer, which is one of the most common cancers in 
women and is usually detected after the typical hysterectomy 
age. Sixteen years ago, in 2004, a study by Luoto et al. showed 
that the hysterectomy- corrected incidence of endometrial can-
cer in Finland was actually 29% higher than the uncorrected 
rate.6 The previous study was performed 20 years ago with data 
ending at the year 1999, considering total and supracervical hys-
terectomy separately; the purpose of the present study was to 
estimate the number and incidence trends of total and supracer-
vical hysterectomy in Finland in the years 1986– 2017 because 
the incidence of hysterectomy has fluctuated over time. In order 
to understand the causes for the possible changes in the hys-
terectomy incidence, we explored the hysterectomy trends by 
treatment indication.
2  |  MATERIAL AND METHODS
The data on hysterectomy were provided by the Care Register for 
Health Care (HILMO) from January 1, 1986, when the recording of 
surgical procedures began, to December 31, 2017. The Care Register 
for Health Care register is maintained by the Finnish Institute of 
Health and Welfare and it contains procedures performed in public 
hospitals; information from the primary health care and private clin-
ics are not covered in our study. The Care Register for Health Care is 
a continuation of the former Hospital Discharge Register. The Care 
Register for Health Care procedure codes are organized until 1995 
according to the procedure classification of the Finnish Hospital 
League and from 1996 onward according to the Nordic Classification 
of Surgical Procedures (Table S1). Procedures were further divided 
into total hysterectomy and supracervical hysterectomy. If duplicate 
procedures were recorded, we considered only the first hysterec-
tomy of a woman.
We included all hospital care episodes with a hysterectomy 
procedure, irrespective of the indication (malignant or benign). The 
main diagnoses of hospital episodes were coded according to the 
Finnish version of the International Classification of Diseases (ICD), 
the eighth version until 1986, the Finnish version of the ninth revi-
sion from 1987 to 1995 and the current version of the 10th revision 
(ICD- 10) starting from 1996 onwards. Additional information of the 
division of diagnosis codes is given in the Supplementary material 
(Table S2). Number of women at the time of the study by age and 
calendar year was obtained from the Digital and Population Data 
Services Agency in Finland. For further analysis, procedures were 
divided into subgroups according to main diagnosis and age docu-
mented at the procedure and by age at the time of procedure.
The incidence rate of hysterectomy was estimated using age- 
period- specific population data. Age- specific weights of the Finnish 
population in 2014 were used for age- adjusted hysterectomy in-
cidence rates. The annual percentage change with time in hyster-
ectomy incidence trends over time was estimated using Poisson 
regression with two points, and so with three intervals.13 The age- 
specific incidence rate by period was fitted using smoothed splines 
and tested for heterogeneity of the period- effect with the likeli-
hood ratio test. We estimated the time trends in different diagnosis 
groups during time with a two- point regression model. Additionally, 
we calculated the cumulative sum of age- specific incidence rates 
during different periods in order to analyze the cumulative burden 
on the healthcare system, i.e. the proportion of women affected by 
hysterectomy during the study period. The analysis was conducted 
using R and packages Epi 2.40, segmented 0.5.4.0, stats 3.6.1 and 
popEpi 0.4.8 (all available in CRAN).
Key Message
After a steady increase during the 1990s, the incidence 
rate of hysterectomy has decreased considerably during 
the past two decades. This change needs to be noted when 
calculating the incidence rate and future predictions of en-
dometrial cancer.
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2.1  |  Ethical Approval
The study was approved by The Finnish Institute for Health and 
Welfare on March 5, 2019 (Permit no. THL/367/6.02.00/2019). As this 
study was a registry- based study, ethical approval was not required ac-
cording to the Act on the Secondary Use of Health and Social Data.27
3  |  RESULTS
From 1986 to 2017 the annual number and incidence rate of 
hysterectomies in Finland underwent considerable changes 
(Table 1, Figure 1). In the first 4- year period (1986– 1989), the 
average annual age- standardized rate of any hysterectomy was 
341/100 000 woman- years, with an average of 8554 hysterec-
tomies annually. The incidence rate of any hysterectomy peaked 
in the period 1998– 2001 to 431/100 000 woman- years and on 
average 11 771 annual hysterectomies. After 2001, the incidence 
has declined and was 224/100 000 woman- years in 2014– 2017 
with on average 6270 annual hysterectomies. In the period 1986– 
1989, 20% of the hysterectomies were supracervical hysterecto-
mies, whereas in the last period of 2014– 2017, this procedure 
type was practically non- existent, constituting only 1.7% of all 
hysterectomies.
TA B L E  1  Annual average number and incidence rates per 100 000 woman- years of supracervical, total and all hysterectomies by 
calendar time period, annual average numbers and rates are age- standardized, duplicates not included
Period













100 000 woman- years
per 
100 000 woman- years
per 
100 000 woman- years
1986– 1989 1801 68 6745 274 8554 342
1990– 1993 1964 70 8201 315 10 170 385
1994– 1997 1093 38 9391 349 10 487 387
1998– 2001 487 17 11 284 414 11 771 431
2002– 2005 229 8 9812 355 10 040 363
2006– 2009 136 5 7156 258 7292 263
2010– 2013 122 4 6846 245 6968 250
2014– 2017 111 4 6159 220 6270 224
F I G U R E  1  Annual age- standardized 
rates of hysterectomy by type of 
procedure, rate per 100 000 woman- years 
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The early period increase and later decrease in the age- specific 
hysterectomy incidence rate has mainly happened in the perimeno-
pausal age group (ages 41– 60 years) (Table 2, Figure 2). In the most 
recent period, an increase in incidence can be observed in the age 
group of 70- to 75- year- old women (Figure 2). The age- specific hys-
terectomy incidence curve has transformed into a more biphasic 
form during recent periods, with a pronounced peak at the age of 
41– 60 years and a second peak at the age of 70– 75 years. The me-
dian age of all hysterectomies during the peak- years period in 1998– 
2001 was 51 years whereas during the most recent study period of 
2014– 2017 the median age was 55 years.
The annual age- adjusted hysterectomy incidence by indication 
is plotted in Figure 3. Before 2000, the most common indication 
for hysterectomy was uterine fibroids. The lifetime risk of having a 
hysterectomy because of uterine fibroids has decreased from 12.8% 
between 1994 and 2001 to 4.8% in 2010 and 2017 (Table 3). After 
2000, hysterectomies decreased rapidly as the result of a decrease 
of procedures based on this indication. For indications such as gen-
ital prolapse or incontinence and malignant neoplasms of genitouri-
nary organs, the risk of having a hysterectomy has remained intact 
(Table 3). For bleeding disorders and endometriosis, the number of 
hysterectomies has decreased from study periods 1994– 2001 to 
2010– 2017, the lifetime risk decreasing from 3.6% to 2.2% for bleed-
ing disorders and from 1.6% to 0.7% for endometriosis (Table 3). For 
the other indication group, the lifetime risk of hysterectomy has de-
creased from 6.1% to 3.7%.
For malignancies, the median age at the time of hysterectomy 
was 64 years during 1994– 2001 and 67 years during 2010– 2017, 
clearly higher than for the other indications even if the lifetime risk 
was at the same level (3.5%– 3.4%) in both periods. The median age 
at the time of hysterectomy performed for all benign indications was 
49 years is 1994– 2001 and 52 years in 2010– 2017. The cumulative 
burden of hysterectomy by the age of 60 was 23.2% in 1994– 2001 
and 11.9% in 2010– 2017, so it has almost halved (Figure 2).
The age- specific hysterectomy rates in periods 1994– 2001 and 
2010– 2017 by indications are plotted in Figure 4. For hysterecto-
mies performed before menopause, the rates have declined for uter-
ine fibroids considerably, and for bleeding disorders, other reasons 
and endometriosis the decrease has been minor. For genital prolapse 
or incontinence and malignancies the trend seems to be more stable.
4  |  DISCUSSION
Hysterectomies are performed today more rarely than before the 
21st century, as during the peak years in 1998– 1999 the incidence 
rate was almost twice that recorded in the most recent years. Uterine 
fibroids are no longer the main diagnosis underlying hysterectomies. 
Indications such as uterine prolapse and incontinence have become 
proportionally more common reasons for the procedure.
Compared with other Nordic countries, Finland's hysterectomy 
rates have changed more radically because of their higher incidence 
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approximately 232 per 100 000 woman- years during the peak year 
of 1999.14 According to NOMESCO (Nordic Medico- Statistical 
Committee. Health Statistics for the Nordic Countries 1995– 2017. 
Available at: http://www.nowba se.org) the rate in Sweden in 2015 
was 175 per 100 000 woman- years, indicating more stable rates 
and lower incidence than in Finland.1 Similar to Sweden, the trend 
has been stable in Norway. In Iceland and in Denmark the incidence 
rates are also decreasing; however, the reduction has not been as 
extreme as in Finland.1 In our study, we have considered all the 
procedures in which a uterus was removed as a hysterectomy, as 
seen in the Table S1, whereas in the NOMESCO analysis procedure 
codes LCD and LCC, which stand for partial hysterectomy and total 
F I G U R E  2  Age- specific hysterectomy 
rates (per 100 000 woman- years) by age 
(A) and cumulative burden (B) by periods 
F I G U R E  3  Annual age- standardized 
rates of hysterectomies by indication. 
Rate per 100 000 woman- years 
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hysterectomy, were considered as a hysterectomy and codes such 
as LEF13/14, which represents hysterectomy in a prolapse of the 
uterus, were left out.
In Finland, the age- specific incidence rate of hysterectomy de-
creased, especially among women of fertile age. There are many 
factors that may have had an impact on the decreasing rates of hys-
terectomies. For example, there are alternative treatment options 
for benign gynecological conditions such as menorrhagia and uterine 
fibroids, which can be treated with endometrial ablation, LNG- IUS 
and other hormonal therapies, uterine artery embolization or oper-
ative hysteroscopy. The use of an LNG- IUS has been estimated to 
be a more cost- effective treatment than hysterectomy, even if the 
patient should end up undergoing a hysterectomy later.15 Since the 
launch of the Finnish study of the LNG- IUS, in the 1990s, this option 
has become popular and has affected especially hysterectomies for 
menorrhagia among other hormonal conditions.16,17 According to 
the Finnish retail statistics of Fimea (The Finnish Medicines Agency), 
which is the authority that regulates pharmaceuticals, the number of 
LNG- IUS sold in 1990 was 7507 and this has been increasing yearly 
up to 51 672 in 2018.18
The decline in hysterectomy rates can be explained by national 
guidelines on how to treat uterine fibroids. In 2005, the Finnish 
Ministry of Social Affairs and Health published the national criteria 
for conditions, for which the alternative treatment had to be given for 
6 months before hysterectomy.11 The reason for this was to secure 
the resourcing of healthcare services so that the timely treatment for 
medically indicated conditions was guaranteed. Although this scor-
ing system is no longer used, the practice changed the mindset of 
Diagnosis
1994– 2001 2010– 2017
Cumulative 
burden (%)




Median age at 
operation (years)
Bleeding disorders 3.6 46 2.2 46
Endometriosis 1.6 45 0.7 43
Genital prolapse or 
incontinence





3.5 64 3.4 67
Uterine fibroids 12.8 48 4.8 48
Others 6.1 51 3.7 55
TA B L E  3  The cumulative burden and 
median age at the time of hysterectomy in 
1990– 1999 and 2008– 2017 by indication
F I G U R E  4  Age- specific hysterectomy 
rates (per 100 000 woman- years) and 
cumulative burden by main diagnosis and 
period 
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gynecologists very rapidly on how to treat uterine fibroids. Current 
practice also reflects a cultural change, which emphasizes treatment 
with more conservative methods and major surgical procedures are 
used more strictly.
The Finnish population is becoming older and more obese, which 
may increase the incidence of genital prolapse and malignant tu-
mors. In this study, we found that the age at the time of procedure 
was shifting towards higher ages and operations on genital prolapses 
and malignant tumors have become the main indications for hyster-
ectomy (Figures 2 and 4).
The strengths of this study are the representative nationwide 
data on hysterectomies, which cover the information of the entire 
population for over 30 years. The private sector covers less than 5% 
of the total number of operations in Finland.19 The use of personal 
identity numbers in Finland provides reliable recording and linkage 
of information. The diagnoses are recorded in the patient records 
at the hospital in connection with the surgery and registered at the 
Care Register for Health Care comprehensively from the hospital 
records. The validity of the Care Register for Health Care has been 
estimated to be from very good to satisfactory.20 According to the 
report, the quality of recording of the main procedures and diagno-
ses to the care register database is very good, but the so- called side 
procedures and diagnoses may lack information.20– 22 Limitations of 
this study are in the process of recording and interpretation of cod-
ing in the Care Register for Health Care. Since the coding system 
of procedures and diagnoses has changed during the study period, 
there may be missing cases and information during the study period, 
especially during the first year of recording.23 Also, the comparison 
of the procedure and diagnosis codes may be difficult because of dif-
ferences in the codes over time, the latest codes being more precise 
than the earlier ones. Very often there are two or even more rea-
sons for hysterectomy. As we classified the procedures into catego-
ries based on the main diagnosis code, it is possible that operations 
classified as being performed for bleeding disorders were actually 
performed because of fibroids, if this was given as the secondary 
diagnosis code.
The impact of the decreasing trend in incidence rate of hysterec-
tomies will become apparent later. A study from the USA suggested 
that uterine/endometrial cancer rates are increasing as the result of 
the practice of retaining the uterus.24 In addition, it is proposed that 
uterine cancer incidence and mortality rates will be higher when hys-
terectomies are taken into account in the population numbers at risk 
than the current observed rates without considering this.24,25 The 
fact that bleeding disorders and fibroids are treated with hormonal 
treatments, can also have protective effects on endometrial cancer 
risk. A recent study from the USA reported, that the proportion of 
high- risk endometrial cancers among endometrial cancer patients is 
increasing and the authors suggested that this might be due to the 
protective effect of LNG- IUS on the low- risk endometrial cancers.26
This study showed that clinicians in Finland currently perform 
fewer hysterectomies for benign indications such as uterine fibroids 
or bleeding disorders, suggesting the use of other treatment mo-
dalities or a decrease in incidence of benign uterine disease. The 
decrease in the incidence rate of hysterectomy has two significant 
implications. First, it affects the demand for healthcare resources. 
Second, and more importantly, it inevitably affects the incidence of 
other uterine diseases, most essentially, the incidence of endome-
trial cancer. Among postmenopausal women in Finland, the popu-
lation of women who have undergone a hysterectomy is currently 
proportionally smaller than 20 years ago and at the same time, the 
population of women who have had a conservative treatment with 
a hormone- releasing intrauterine system has increased. A failure to 
correct uterine cancer incidence rates to the actual population at 
risk (women with intact uterus) leads to incorrect estimates of endo-
metrial cancer incidence, as reported earlier.6
The results of our study show that, in Finland, the hysterectomy 
rates have varied markedly during the last three decades, and there 
is valid reason to adjust endometrial cancer incidence rates, as well 
as future predictions on endometrial cancer incidence in line with 
these changes. These changes might have an effect not only on en-
dometrial cancer incidence, but also on the histological distribution 
of endometrial cancer in the future and mortality due to gynecolog-
ical cancers, which may require new measures in the treatment of 
the patients.
5  |  CONCLUSION
The availability of hormonal and other conservative treatment meth-
ods for uterine fibroids and bleeding disorders has led to a significant 
decrease in hysterectomy incidence in Finland during the last two 
decades. The impact of this on future incidence and mortality of en-
dometrial cancer needs to be evaluated.
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